Lee Jae-yong, president of Samsung Biologics (AP Photo/Ahn Young-joon)
As leader is freed from prison, Samsung Biologics nabs massive investment from parent company's $205B spending spree
One of biotech manufacturing’s giants has announced a massive investment in its operations over the next three years.
Samsung Biologics will receive a share of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.